• 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

JPHM Share Price Performance

د.أ1.50
0.01 (0.67%)
د.أ1.50
0.01 (0.67%)
Price د.أ1.50

JPHM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with acceptable track record.

3 Risks
2 Rewards

The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company Key Details

د.أ24.5m

Revenue

د.أ12.1m

Cost of Revenue

د.أ12.4m

Gross Profit

د.أ7.5m

Other Expenses

د.أ4.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.14
50.68%
19.88%
356.5%
View Full Analysis

About JPHM

Founded
1978
Employees
n/a
CEO
Abdul Hamid Sinokrot
WebsiteView website
www.jpm.com.jo

The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company, together with its subsidiaries, develops, manufactures, and sells branded generic pharmaceuticals in Jordan and internationally. It offers its products in various forms, such as tablets, capsules, suppositories, injectable, syrups and suspensions. The company provides various pharmaceutical products, such as cardiovascular, gastrointestinal, central nervous system, anti-infective, endocrine, musculoskeletal, respiratory, obstetrics, gynecology and urinary tract, immune system, anti-diabetics, anti-inflammatory and analgesic, musculoskeletal, and genitourinary drugs, as well as vitamins and supplements. It is also involved in the development and production of plant and herbal medical products; and diagnostic test kits for home and laboratory use, as well as focuses on the development of proprietary, specialized drug delivery systems, and pharmaceutical additives. The company was founded in 1978 and is headquartered in Naour, Jordan.

Recent JPHM News & Updates

Recent updates

No updates